Norris Medicines
NORRISBSE

Norris Medicines

₹14.110.60 (4.44%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
13.00
Today’s high
14.30
52 week low
12.00
52 week high
19.90
Open price
13.50
Previous close
13.51
Live volume
1,704
Lower circuit
12.70
Upper circuit
15.52

Fundamentals

Market Cap
₹14Cr
ROE
1.85%
P/E Ratio(TTM)
--
EPS(TTM)
-0.28
P/B Ratio
0.00
Dividend Yield
0.00%
Industry P/E
45.21
Book Value
-15.07
Debt to Equity
-1.42
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹1.43
-56.27%
Profit (Cr)
₹0.05
-92.86%
-2-50 L01.53
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)-48%
3Y CAGR-15%
Profit growthValue
1Y (TTM)+122%
3Y CAGR+38%

About

Norris Medicines Limited manufactures pharmaceutical formulations, including injectables and tablets, catering to domestic and export markets.;
CEO/MD
Vimal Dhirendra Shah
Founded in
1990
BSE symbol
524414

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Retail And Others
65.92%
Promoters
34.01%
Other Domestic Institutions
0.06%
Mutual Funds
0.01%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹1,218.10
+36.90 (3.12%)
L
    H
    25,854.7674.110.41
    ₹17,198.00
    +225.00 (1.33%)
    L
      H
      22,038.5460.5511.76
      ₹163.85
      +2.54 (1.57%)
      L
        H
        21,814.14--2.67
        ₹458.55
        +10.60 (2.37%)
        L
          H
          18,512.2758.423.82
          2026
          30
          May
          Annual Result
          Release date
          14
          Feb
          Result
          Release date
          2025
          14
          Nov
          Quarterly Result
          Release date
          14
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks